CarlosEduardoMillaMD

Associate Professor, Pediatrics - Pulmonary Medicine, Stanford University Medical Center

Dr. Milla is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
725 Welch Rd
Palo Alto, CA 94304
Phone+1 650-497-8000

Fax+1 650-723-5201

PubMed

Double CF Combination Safe, Effective in 1- to 2-Year-OldsDecember 30th, 2022
Scientists Decipher the Danger of Gummy Phlegm in Severe COVID-19June 24th, 2022
Stanford Scientists Decipher the Danger of Gummy Phlegm in Severe COVID-19June 22nd, 2022
Join now to see all

Inhaled Sodium Pyruvate For The Treatment Of Cystic Fibrosis A Phase I, DoubleNational Center For Research Resources2007
A Double-Blind, Randomized, Placebo-Controlled, 28-Day Study Of Denufosol TetrasNational Center For Research Resources2007
A Phase 3, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial WithNational Center For Research Resources2006–2007
Assessment Of Induced Sputum As A Tool To Evaluate Anti-Inflammatory Agents In CNational Center For Research Resources2006
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, 28-Day Study Of DNational Center For Research Resources2006
Multi-Center, Double-Blind, Placebo-Controlled, Phase II Study Of Aerosolized TGNational Center For Research Resources2004–2006
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, 28-Day Study Of InNational Center For Research Resources2005
Safety And Tolerability Study Of Aztreonam For Inhalation In Cystic FibrosisNational Center For Research Resources2004